United States · Who invested in Replidyne?
Replidyne's investors include Morgenthaler Ventures, Johnson & Johnson Development Corporation (JJDC), HealthCare Ventures and Sequel Venture Partners.
United States · Series A startup
Who invested in Replidyne
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$13Mraised across 1 round since 2002, from 1 source
- Latest round
- Series A, $13MApr 2002
- Investors
- 4
The rounds
- Apr 2002Series A$13M
Morgenthaler VenturesJohnson & Johnson Development Corporation (JJDC)
- HealthCare Ventures
- Sequel Venture Partners
From a historical funding record
The exit
ExitBuyerPriceWhen
From historical deal records. Wrong? Tell us.
Everyone who backed them
HealthCare VenturesGrowth equity1round
Sequel Venture PartnersVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Replidyne
How much has Replidyne raised?
Replidyne has raised $13M across 1 round since 2002.
When did Replidyne last raise?
Replidyne's most recent round was a Series A of $13M in Apr 2002.
What was Replidyne's biggest round?
Its most recent round, $13M in Apr 2002, is also its largest on record.
Who backed Replidyne first?
Replidyne's first round on record, in Apr 2002, was backed by Morgenthaler Ventures, Johnson & Johnson Development Corporation (JJDC) and HealthCare Ventures and 1 others.
What stage is Replidyne at?
Replidyne's latest named round is a Series A, in Apr 2002.
Where is Replidyne based?
Replidyne is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.